Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8545-8557
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8545
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8545
Figure 5 Changes of epithelial and mesenchymal markers of pancreatic cancer cells by clobenpropit.
Real-time polymerase chain reaction shows that E-cadherin was up-regulated (A), whereas MMP-9 and vimentin were down-regulated (B, C) in pancreatic cancer cells after treatment with different concentrations of clobenpropit.
- Citation: Paik WH, Ryu JK, Jeong KS, Park JM, Song BJ, Lee SH, Kim YT, Yoon YB. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8545-8557
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8545.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8545